نتایج جستجو برای: mucous membrane pemphigoid

تعداد نتایج: 393503  

Journal: :Journal of Investigative Dermatology 2020

Journal: :American Journal of Ophthalmology Case Reports 2021

Journal: :Journal of Bronchology & Interventional Pulmonology 2017

Journal: :Japanese Journal of Oral & Maxillofacial Surgery 1980

Journal: :Journal 2005
Mark R Darling Tom Daley

Oral mucous membranes may be affected by a variety of blistering mucocutaneous diseases. In this paper, we review the clinical manifestations, typical microscopic and immunofluorescence features, pathogenesis, biological behaviour and treatment of mucous membrane pemphigoid (MMP). As MMP is a relatively common condition, the general dentist must be able to diagnose, treat and monitor the progre...

Journal: :Obstetrics and gynecology 2005
Andrew T Goldstein Grant J Anhalt Daisy Klingman Lara J Burrows

BACKGROUND Mucous membrane pemphigoid is a rare autoimmune blistering disease primarily affecting mucosal surfaces. Blistering and scarring may occur in the eyes, mouth, esophagus, larynx, and on the vulva. Scarring can result in severe structural changes to the vulva that may mimic the findings of other inflammatory dermatologic disorders of the vulva, including lichen sclerosus and lichen pla...

Journal: :Oral diseases 2014
G Di Zenzo M Carrozzo L S Chan

Mucous membrane pemphigoid (MMP) is a heterogeneous group of autoimmune subepithelial blistering diseases affecting primarily mucous membranes showing marked degree of clinical and immunological variability. We investigated four controversial topics: (i) Does oral pemphigoid (OP) really exist as a separate entity? (ii) Is mucous membrane pemphigoid curable? (iii) What is the best therapeutic op...

Journal: :JAMA dermatology 2015
Yong He Michiko Shimoda Yoko Ono Itzel Bustos Villalobos Anupam Mitra Thomas Konia Sergei A Grando John J Zone Emanual Maverakis

IMPORTANCE Immunobullous diseases mediated by IgA are often difficult to manage, but to date no mechanism has been proposed. Rituximab is an anti-CD20 monoclonal antibody that has demonstrated good efficacy in the treatment of refractory mucous membrane pemphigoid. However, not all cases of mucous membrane pemphigoid respond to rituximab. Herein we present a case of treatment-refractory mucous ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید